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Abstract: Complex diseases, such as allergy, diabetes and obesity depend on altered interactions
between multiple genes, rather than changes in a single causal gene. DNA microarray studies of a
complex disease often implicate hundreds of genes in the pathogenesis. This indicates that many
different mechanisms and pathways are involved. How can we understand such complexity? How can
hypotheses be formulated and tested?
One approach is to organize the data in network models and to analyze these in a top-down manner.
Globally, networks in nature are often characterized by a small number of highly connected nodes,
while the majority of nodes have few connections. The highly connected nodes serve as hubs that
affect many other nodes. Such hubs have key roles in the network. In yeast cells, for example,
deletion of highly connected proteins is associated with increased lethality, compared to deletion of
less connected proteins.
This suggests the biological relevance of networks. Moving down in the network structure, there may
be sub-networks or modules with specific functions. These modules may be further dissected to
analyze individual nodes. In the context of DNA microarray studies of complex diseases, gene-
interaction networks may contain modules of co-regulated or interacting genes that have distinct
biological functions. Such modules may be linked to specific gene polymorphisms, transcription
factors, cellular functions and disease mechanisms. Genes that are reliably active only in the context
of their modules can be considered markers for the activity of the modules and may thus be promising
candidates for biomarkers or therapeutic targets.
This review aims to give an introduction to network theory and how it can be applied to microarray
studies of complex diseases.
INTRODUCTION
Complex diseases involve multiple genes. In
allergic disease, for example, genome-wide linkage
studies have shown more than 20 susceptibility loci.
DNA microarray studies reveal hundreds of
differentially expressed genes in cells and tissues
from patients with complex diseases [1]. In a typical
microarray article these genes are listed, some
commented on, and one or two chosen for detailed
analysis. In essence, such an article is based on two
scales, one global and one detailed. While the
detailed scale can give new and interesting
information, the reason for highlighting a specific
gene, and its importance relative to other genes, are
often quite subjective. Moreover, analysis on the
global level may be unstructured and uninformative.
A structured way of describing both the global and
detailed structure of the results is desirable.
Essentially, this is the same idea as with a
microscopic examination. You start with a low
magnification to get a general overview of the tissue
and then increase magnification to examine selected
substructures and single cells. In this article the
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possibility of using network approaches for such top-
down analysis of microarray data will be discussed.
NETWORKS IN BIOLOGY
Networks provide an intuitive and visually
appealing way of organizing large amounts of data.
They may convey a global view of a biological
system, as well as its local details.
The general definition of a network is simple: It
consists of a large number of nodes , which are
unique elements (e.g. genes, proteins or
metabolites) and edges, each of which corresponds
to a pair-wise relationship between two of the nodes.
The relationship that is encoded by the edge can
have an extremely wide range of interpretations,
making networks very flexible for the representation
of biological knowledge.
The simple mathematical definition of networks
leads to a very straightforward way to describe a
biological network. In most cases, a single table
(produced, e.g., in a spreadsheet program like Excel)
is sufficient to encode all information, and these
general network files can then be read by many
analysis- and visualization tools. Such a table might
look as follows:
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First Node Second Node Edge Description
Transcription Factor X Transcription Factor Y up-regulates
Transcription Factor Y Repressor Molecule Z up-regulates
Repressor Molecule Z Transcription Factor X inhibits
This simple example would correspond to a small
transcriptional network of a negative feedback loop.
The description of the edges can be standardized,
so that only certain ways of interaction are allowed,
or it can contain additional quantitative information,
such as the strength and kinetics of an up-
regulation. Also, the nodes can be further defined
by, e.g., quantitative data on the concentrations of
the compounds in a particular physiological state.
Such specifications, however, as well as potential
layout information for the display of a network, will
usually depend on the specific application software
that is used, while the underlying general network
description will be shared by almost any program.
There are two major types of network descriptions
in biology. In the first type, an edge between two
nodes implies a direct physical interaction between
the nodes. An example is a protein interaction
network. If two proteins are connected, they are
known to bind to each other in some kind of
biological assay. Other examples are metabolic
networks, where metabolites are connected
whenever they participate in the same enzymatic
reaction or, alternatively, whenever one of them can
be converted chemically into the other one. Such a
substrate → product relationship indicates a further
possibility of refining the definition of the network: All
edges could have a defined direction, so that in the
graphical representation they would be represented
by arrows pointing from one node (source) to
another (target).
A further example of a directed, physical network
would be a gene regulation network, where an arrow
from gene A to gene B would imply that the product
of gene A influences the expression of gene B. An
example is the fascinating model of sea urchin
development by Davidson et al. [2] The automated
inference of such regulatory networks from gene
expression data is a major challenge in statistical
bioinformatics, and a number of publications report
successes in this area [3-6]. These are now being
complemented by the results of genetical genomics
studies, that combine expression measurements and
genotyping in large populations to allow more
precise causal inference than any of the two
approach alone [7-9].
The second major type of network involves
conceptual, rather than physical, interactions
between nodes. For example, an edge could
translate as
• “Gene A participates in the same physiological
process as Gene B” (functional network), or
• “The expression changes of Gene A and
Gene B look the same in many experiments”
(expression correlation network; see Fig. 1 for
an example), or
• “A combined knock-out of Gene A and Gene B
is always lethal” (genetic interaction network),
or even
• “Gene A is very often mentioned in the same
papers as Gene B” (co-citation network).
Fig. (1). Expression correlation networks. Gene expression
patterns in multiple tissues and conditions can be
visualized in multi-dimensional space (reduced to 2
dimensions in the figure). The closer two dots (genes or
samples) are, the more similar are their expression
patterns. In one highly popular approach (clustering), the
aim is to identify groups of genes (or samples) that are
similar and distinct from other samples. In the network
approach presented in the present paper, genes are
connected when their similarity (expression correlation) is
above a certain threshold, i.e. if they are close in
expression space. This may give more flexibility than
“hard” clustering, but interpreting the results requires
biological expertise.
All of these conceptual networks may be easier to
generate than the physical networks. On the other
hand, much of their usefulness derives from an
inverse guilt-by-association principle: Genes that are
connected by one of the more abstract concepts
(e.g. by being mentioned in the same papers) are
also expected to be biologically “close”, i.e. they may
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Fig. (2). Examples of networks. The figure shows three general types of network topology. In the first case, nodes are
connected in a regular pattern, all nodes tending to have very similar connectivities (regular network). In the second case,
nodes are randomly connected, any possible connection being as likely as any other (random network). In the third case,
nodes are also randomly connected, but in such a way that one node, the hub, is much more strongly connected than
would be expected in an entirely random network (small-world network). As the name implies, this leads to a reduction in
the average path length, s, as indicated below the networks. This effect would be even stronger in larger networks. All
three examples have 9 nodes and 11 edges.
participate in the same physiological processes or
influence the same complex disease phenotypes. A
very active research area in current bioinformatics
aims at generating “physical” networks (such as gene
regulation pathways) from “conceptual” networks
(such as co-expression information) [10].
NETWORK TOPOLOGY AND PHYSIOLO-
GICAL FUNCTION
One of the most striking findings of network
analysis in biology has been that the overall
structure of the networks is far from random. One
could have assumed that the average probability
that two genes are associated in one way or another
is fairly uniform, but this is not the case. In general,
all biological networks so far examined are
characterized by a small number of highly connected
nodes, while most other nodes have few
connections. This is known as a power-law
distribution of connections. The highly connected
nodes act as hubs that mediate interactions
between other nodes in the network [11] (see Fig. 2
for examples of network types). This has an
important implication; hubs have key roles in the
networks. A “hub-centered” design, which is similar to
the layout of the internet, yields good overall stability
of a network against malignant changes (“attacks”).
This stability arises because the majority of nodes
are low connectors which can be deleted without
major global effects. However, hubs are particularly
vulnerable, because changes to them will have
drastic consequences all over the network. Evolution
of a physiological system should lead to a
compromise between increased vulnerability of hubs
and increased stability of the complete system.
One of the first examples of a network theoretical
analysis in biology was provided by Jeong et al. who
showed that the connectivity in protein interaction
networks in yeast cells followed an approximate
power-law distribution [12]. Thus, a small number of
proteins were highly connected to many other
proteins. This property, which has become famous
as the “power-law distribution of degrees” [11], has
important consequences for the potential behavior of
the system. For example, because of the sensitivity
of hubs to mutation, any change in them will have
large consequences for the entire system. Thus,
they will often be represented by essential genes. In
fact, deletion of “hub” proteins was associated with
increased yeast cell lethality compared to deletion of
less connected proteins [12]. This supports a key
role for hubs. These properties of biological networks
are also popularly referred to as "scale-free"
topology, borrowing a term that was originally
developed to characterize similar networks in
theoretical physics. However, Khanin and Wit [13]
present compelling evidence supporting the
conclusion that experimental networks are not scale-
free in the technical, mathematical sense. This has
to be kept in mind when the evolution and relevance
of the topological properties of biological networks
are discussed. This is still an area of active and
controversial research. Another interesting biological
conclusion from network theory is that hub genes are
highly conserved through evolution [11]. By contrast,
mutations in other genes are more likely to be
transmitted because they are less likely to affect
survival.
The power-law distribution of degrees is closely
related to the so-called 'small-world property' of
biological networks [3], which means that every node
can affect or associate to each other node via a
small number of steps. This potentially has huge
implications for complex disease traits: Small-world
behavior of physiology and gene regulation raises
the question if a change almost anywhere in the
system may lead to pervasive pleiotropic effects. In a
highly-connected, small-world neighborhood of the
biological system, a change in any (albeit non-
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essential) gene has the possibility to affect many
other genes and functions, and, although these
effects will often be mild and not always of
pathophysiological relevance, they may still be
picked up by microarrays and can contribute to the
interpretation of the global physiological picture.
Biological networks are not only non-random in
their global properties (such as their small-world
characteristics), but also show important patterns at
the local level. Biological entities show a strong
inclination to be connected in characteristic ways.
The shape and meaning of such “network motifs”
[14] will vary widely between different types of
network, but may be diagnostic for a certain kind of
biological function. For example, in gene regulatory
networks, a gene that is influencing the expression
of many downstream genes may stand out as an
important regulator, most likely a transcription factor
or signaling molecule. A problem may be that many
transcription factors are not transcriptionally
regulated and therefore will not be picked up in
classical microarray studies. Genetical genomics
experiment may be able to overcome this important
limitation. On the other hand, in a protein interaction
network, a gene product that binds to a large
number of other gene products, which in turn are
connected to each other, can confidently be
predicted to be a subunit of a protein complex.
Considering that gene-gene regulatory connections
can be either positive (activation) or negative
(inhibition) even more interesting patterns emerge,
for example an overrepresentation of certain
feedback loops that can stabilize or amplify
expression responses [14]. Genes that are involved
in such network motifs can then be assigned to
putative roles based purely on their connectivity,
even without requiring additional biological
information about their actual biochemistry.
NETWORKS AND MICROARRAYS
All these findings suggest that networks can be
useful to organize large amounts of biological
information, in particular gene expression data.
Networks may for example, help to find modules of
functionally related genes and “hub” genes with key
regulatory roles. In this section we review
applications of network approaches to microarray
analysis.
Carter et al. used a very straightforward approach
and built a gene correlation network from expression
data, in which genes were connected when their
expression profiles were correlated to a significant
degree [15]. The authors report an apparently scale-
free structure of these networks, but point out that
the clustering coefficient is much larger than would
be expected in a scale-free network. They interpret
this as an indication of modularity in the network.
The most likely explanation for such an effect is the
presence of gene groups (modules) that are all
regulated strongly (and exclusively) by a common
transcription factor (or combination of transcription
factors). An example of such a module, which is
widely observed in many microarray studies, is the
cluster of ribosomal genes. These respond strongly
and in a coordinated fashion in gene expression
studies in many organisms, cell types and conditions.
Carter et al. [15] also observe an enrichment of
lethal knock-out phenotypes among the high-degree
nodes of their network. In addition they find an
enrichment of condition-specific genes among the
hubs. Both of these observations indicate that even
in a simple correlation network like this, network
theory can predict important physiological factors.
Many other microarray studies of different
organisms and conditions have revealed conserved
modules of co-expressed genes. Such modules
correspond to distinct functions. In one such study
based on more than 3000 microarray experiments
conserved co-expression modules were associated
with specific cellular functions such as lipid
metabolism and cell cycle [16]. Such a module could
be used to predict the function of an unknown gene
by comparing it with neighboring genes in the
module. Bergmann et al. also report modules of
conserved interaction networks in different organisms
[17].
In another study, Lee et al. [18] examine co-
expression relationships of genes across 60 different
large human data sets, comprising a total of 3924
microarrays. They identify genes that are
reproducibly co-expressed in the various studies at
high statistical significance and build a high-
confidence network of 8805 genes connected by
220,649 co-expression links. This number is much
higher than in the previous study, as only a single
organism albeit in widely diverse conditions was
considered. The authors report a clear prepon-
derance of positive expression correlations, perhaps
because the underlying molecular apparatus is
designed to co-activate/co-repress genes, rather
than changing them in opposite directions.
In agreement with Stuart et al. they detect
functionally related clusters in the network that
correspond to processes like protein biosynthesis
and cell-cycle [16]. They also report that even co-
expressions that are observed only in a few datasets
are biologically informative and enriched for non-
random relationships.
Comparative analysis can also be used to find
conserved co-expression modules involved in cellular
processes and disease. For example, McCarrol et al.
found common modules that were associated with
aging in worms and flies. These modules included
orthologous genes involved in mitochondrial
function, DNA repair and cellular transport. A similar
approach was used to find modules involved in
cancer. Sweet-Cordero et al. identified a module
associated with lung cancer in three mouse models
and a corresponding module of orthologous genes
in human cancer [19]. The approach can also be
extended to describe regulatory modules containing
both regulatory factors and the corresponding down-
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stream module of co-regulated genes. Such a
module was identified in mice and its human
orthologue is associated with cancer [20]. These
experiments indicate how modules can be used for
meaningful organization of microarray data on a
global scale.
In the context of human microarray studies Basso
et al. recently showed that a gene regulatory
network reconstructed from B lymphocyte expression
data had approximately scale-free properties [21].
They focused on the sub-network centered around
the transcription factor myc. Using bioinformatics
methods they found that several of the genes in the
sub-network contained response elements of myc,
many of which were verified experimentally. Hub
genes were enriched among the myc  targets,
confirming its central (patho-)physiological role as a
master regulator of cell proliferation [22].
About 5% of the B lymphocyte genes were hubs.
It is interesting to note that about the same
percentage of eukaryotic genes are transcription
factors [23]. This could indicate that a large number
of hubs are transcription factors. Taken together, this
data supports once more the validity of applying
network theory to networks derived from gene
expression data from microarray studies.
Moreover, Segal et al. suggested that modules
can be used as basic building blocks when
attempting to understand biological effects [20].
Modules are easier to interpret than hundreds or
thousands of differentially expressed genes. Also,
subtle but coordinated changes of genes in modules
are easier to discern than changes in individual
genes. An early example of linking modules to
biological effects was given by a study of apoptosis
in diabetic muscle [24]. A specific module was linked
to apoptosis. A meta-analysis of multiple microarray
studies of cancer reported a large compendium of
cancer-specific modules [20]. These modules
contained genes that were co-expressed in many
different experiments. The modules corresponded to
different functions such as cell cycle or growth
regulation. These modules could be represented in a
causal chain, with transcription factors upstream and
biological functions, such as cell growth or apoptosis,
down-stream. Together, these modules formed a
network map of transcriptional changes in cancer.
The map or modules within it could be used to gain a
mechanistic understanding of the disease process.
For example, decreased expression of genes in a
growth inhibitory module in acute leukemia,
suggested a possible explanation for uncontrolled
growth in this form of cancer. Other modules were
shared across many different forms of cancer,
indicating a common disease mechanism.
Combinations of such modules could be associated
with different types and stages of cancer. This
showed the usefulness of analyzing complex
processes in terms of modules, rather than individual
genes.
NETWORKS IN COMPLEX DISEASE
Associating modules with transcription factors and
down-stream cellular processes in causal chains,
also shows how directionality can be introduced in
network models. One way to change from
associative to directed, causal networks was
described by Chesler et al. [8]. Their work was based
on the observation that quantitative differences in
gene expression are heritable. They used a panel of
several inbred generations of mice. Their aim was to
link heritable differences in gene expression to
genetic loci in these mice. In other word gene
expression was treated as a quantitative trait and
the loci identified as quantitative trait loci (QTL).
mRNA samples from each inbred mouse line were
analyzed with microarrays. It was shown that
heritable differences in gene expression could be
related to specific genetic regions (QTLs). By
inference, these QTLs should contain either cis- or
trans-regulatory elements that cause the expression
difference. If a differentially expressed gene was
located in a QTL responsible for its expression
regulation, that gene was expected to be cis-
regulated, e.g. by having a polymorphism in its
upstream regulatory region. Trans-regulated
modules, which are not themselves polymorphic, but
respond to genetic differences in some regulatory
gene, could contain more than a thousand genes.
Another interesting finding was that, since
phenotypic QTLs were also known for the multiple
mouse generations, regulatory modules could also
be linked to physical traits.
If network models can be built that describe
transcription factors, modules, and down-stream
biological effects such as cellular processes or
disease, the next step in a top-down analysis would
be to dissect the models to find individual genes with
key functions.
In natural cellular processes transcription factors
are key regulatory genes, since they are up-stream
regulators of multiple genes. Indeed, the work by
Chesler et al. suggested that a single transcription
factor could regulate (directly or indirectly) the
expression of thousands of genes [8]. Also, from a
networks perspective transcription factors are likely to
have key roles since they are often highly connected
hubs. It remains to be demonstrated that
transcription factors or other highly connected genes
also have key roles in complex diseases.
Because hubs are more often essential for
survival, deleterious mutations in them are less likely
to be transmitted across generations than in the
case of non-essential genes. Indeed, as stated
above, hubs are more conserved than non-hubs
[11]. By contrast, yeast cell experiments indicate that
mutations in non-essential genes can accumulate in
populations [25]. If these mutations occur in genes
that do not interact, the risk of affecting cell fitness is
small. However, yeast cell experiments involving
mutations in pairs of genes indicated that mutations
in pairs of interacting genes are much more likely
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affect cell fitness. The authors reasoned that the
same principle could be applied to complex
diseases.
In other words, mutations in non-essential genes
occur frequently as they are less likely to affect the
evolutionary fitness of a carrier. However, if such
mutations become frequent enough in the
population, at one point it becomes likely that a
single person will carry mutations in interacting non-
essential genes. And while none of the individual
mutations have serious effects, their combination
may be severe and can result in disease. An
example of such a human disease is retinitis
pigmentosa, which is caused by mutations in two
genes that are asymptomatic singly, but together
cause the disease [26]. While this is not yet a
“complex disease”, it serves well to illustrate the
general principle. Another related example is
provided by cystic fibrosis. Although this is caused by
mutations in a single gene, disease severity is
strongly affected by mutations in several other genes
[25].
It is of interest in this context, that the small-word
property of networks implies that most genes may
interact through only a small number of intermediary
genes. This could increase the risk of disease-
associated interactions between mutated genes.
Linkage studies of complex diseases like allergy
have described multiple loci, and it is possible that
these contain mainly interacting non-essential
genes. This possibility indicates how networks in
combination with other sources of information such
as linkage studies and bioinformatics methods could
be used to pin-point combinations of mutations in
different genes in complex disease. To our
knowledge, this has not yet been shown.
FUTURE CHALLENGES
Apart from the quantitative complexity associated
with analyzing 25,000 genes simultaneously, several
biological factors may confound the interpretation of
networks based on network models of transcriptomal
changes:
• Changes in mRNA may not correspond to
changes in protein levels due to variable
translation or protein degradation.
• There may be post-translation modifications of
proteins. For example, transcription factors are
seldom regulated on the transcriptional level.
• Co-expressed genes may occur in different
sub-cellular compartments and not interact
physically in the same cellular process.
• Genetic polymorphisms may cause important
changes which are not detected by
microarrays, e.g. in posttranslational
processing or protein stability.
• A vast majority of translational variation may be
“physiological noise”. Even though it has been
shown that exact transcript levels will in many
cases be under evolutionary control [27], some
variation will be the spurious result of the high
connectivity and small-world properties of
transcriptional networks.
• Microarray analysis of complex tissues is
confounded by variable cell populations, some
of which may not be associated with the
biological problem that is studied. Interestingly,
computational methods comparing histological
information with gene expression data may
help address this problem [28].
CLINICAL APPLICATIONS
The examples described above suggest that
identification of modules of functionally related
genes may help to understand pathways involved in
complex diseases as well as in response to
treatment. This information could lead to
identification of biomarkers for improved diagnosis as
well as for individualized medication. DNA
microarrays containing selected genes are already
used diagnostically when treating patients with
breast cancer [29]. It is conceivable that the same
principles could be useful in other complex diseases.
It should be noted, however, that at present there
are no validated clinical tests based on applying
network theory to microarray data.
SUMMARY
Organizing microarray data in network models
may help understanding complex diseases on both
the global and detailed scale. Although significant
methodological and theoretical challenges remain,
this may have clinical implications, such as
identification of biomarkers and therapeutic targets.
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